Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 known ✓ | P0DMS8 | 1/20 | 0.72 |
| ▸ | AKT1 | P31749 | 3/20 | 0.72 |
| ▸ | CDC25A | P30304 | 2/20 | 0.72 |
| ▸ | LMNA | P02545 | 2/20 | 0.72 |
| ▸ | ESR1 | P03372 | 1/20 | 0.72 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.72 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.72 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.72 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.59 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.59 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.59 |
| ▸ | TERT | O14746 | 1/20 | 0.54 |
| ▸ | UCHL3 | P15374 | 1/20 | 0.54 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.50 |
| ▸ | PRKCG | P05129 | 1/20 | 0.50 |
| ▸ | PRKCB | P05771 | 1/20 | 0.50 |
| ▸ | PRKCA | P17252 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28355527 | 1.00 | AKT1 (0.72) | AKT1CDC25ALMNAESR1ADORA3 | |
| SCHEMBL28355399 | 1.00 | AKT1 (0.72) | AKT1CDC25ALMNAESR1ADORA3 | |
| SCHEMBL28355525 | 1.00 | AKT1 (0.72) | AKT1CDC25ALMNAESR1ADORA3 | |
| SCHEMBL10435761 | 1.00 | AKT1 (0.72) | AKT1CDC25ALMNAESR1ADORA3 | |
| SCHEMBL2211526 | 1.00 | AKT1 (0.72) | AKT1CDC25ALMNAESR1ADORA3 | |
| SCHEMBL4071722 | 1.00 | AKT1 (0.72) | AKT1CDC25ALMNAESR1ADORA3 | |
| SCHEMBL6869674 | 1.00 | AKT1 (0.72) | AKT1CDC25ALMNAESR1ADORA3 | |
| SCHEMBL1005430 | 1.00 | AKT1 (0.72) | AKT1CDC25ALMNAESR1ADORA3 | |
| SCHEMBL596158 | 1.00 | AKT1 (0.72) | AKT1CDC25ALMNAESR1ADORA3 | |
| SCHEMBL29067116 | 1.00 | AKT1 (0.72) | AKT1CDC25ALMNAESR1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 340 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025084522-A1 | METHOD AND APPARATUS FOR MANUFACTURING LITHIUM CERAMIC PEBBLES FOR TRITIUM BREEDING MATERIALS | 가천대학교 산학협력단 | 2025-04-24 | — | — | WO | claimed |
| US-12057585-B2 | Conductive composition for secondary battery | GRST INTERNATIONAL LIMITED (CN) | 2024-08-06 | — | — | US | claimed |
| CN-117899931-B | Synthetic method of pentamethyl indane | 山东新和成药业有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-117899931-A | Acidic composite catalyst for synthesizing pentamethylindane and synthesis method | 山东新和成药业有限公司 | 2024-04-19 | — | — | CN | claimed |
| WO-2023216719-A1 | ALKYL PHOSPHINATE COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 江苏利思德新材料股份有限公司 | 2023-11-16 | — | — | WO | claimed |
| CN-116948622-A | Nanometer microemulsion oil displacement agent and preparation method thereof | 陕西万朗石油工程技术服务有限公司 | 2023-10-27 | — | — | CN | claimed |
| US-20230343963-A1 | CONDUCTIVE COMPOSITION FOR SECONDARY BATTERY | GRST INTERNATIONAL LIMITED (HK) | 2023-10-26 | — | — | US | claimed |
| EP-4094315-A1 | CONDUCTIVE COMPOSITION FOR SECONDARY BATTERY | GRST International Limited (CN) | 2022-11-30 | — | — | EP | claimed |
| CN-114287075-A | Conductive composition for secondary battery | 广东省皓智科技有限公司 | 2022-04-05 | — | — | CN | claimed |
| WO-2021253302-A1 | CONDUCTIVE COMPOSITION FOR SECONDARY BATTERY | GUANGDONG HAOZHI TECHNOLOGY CO. LIMITED (CN) | 2021-12-23 | — | — | WO | claimed |
| US-20130222510-A1 | RESISTANCE HEATING COMPOSITION, HEATING COMPOSITE USING THE COMPOSITION, METHOD OF PREPARING THE HEATING COMPOSITE, AND HEATING APPARATUS AND FUSING APPARATUS USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-08-29 | — | — | US | claimed |
| CN-102059836-A | Heat-shrinkable biaxially oriented film | ZHONGSHAN TORCH POLYTECHNIC | 2011-05-18 | — | — | CN | claimed |
| US-20100316579-A1 | NOVEL USE OF ALKYL PHOSPHATE ESTERS | GLAXO GROUP LIMITED | 2010-12-16 | — | — | US | claimed |
| US-20090214648-A1 | PHARMACEUTICAL FORMULATIONS COMPRISING IBUPROFEN AND DIPHENHYDRAMINE | DR. REDDY'S LABORATORIES, INC. | 2009-08-27 | — | — | US | claimed |
| EP-2073784-A1 | NOVEL USE OF ALKYL PHOSPHATE ESTERS | Glaxo Group Limited (GB) | 2009-07-01 | — | — | EP | claimed |
| WO-2008049878-A1 | NOVEL USE OF ALKYL PHOSPHATE ESTERS | GLAXO GROUP LIMITED (GB) | 2008-05-02 | — | — | WO | claimed |
| EP-0785247-B1 | REFRIGERATOR OIL COMPOSITION | IDEMITSU KOSAN CO (JP) | 2003-11-19 | — | — | EP | claimed |
| US-5858266-A | CONTAINING A HYDROFLUOROCARBON, A PHOSPHOROUS COMPOUND AND AN OXYGEN-CONTAINING ORGANIC COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 1999-01-12 | — | — | US | claimed |
| EP-0785247-A1 | REFRIGERATOR OIL COMPOSITION | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1997-07-23 | — | — | EP | claimed |
| US-5393461-A | For use in cosmetics, paints, drugs,inks; mixing powder with anionic, cationic, amphoteric, nonionic surfactants, oils, solvents, wetting agents and water, emulsification | RTD CORPORATION (US) | 1995-02-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100316579-A1 | NOVEL USE OF ALKYL PHOSPHATE ESTERS | PHOSPHO1, NAPEPLD, DCPS | ADORA3 1537/4885AKT1 4329/4885CDC25A 3266/4885 |
| US-20090214648-A1 | PHARMACEUTICAL FORMULATIONS COMPRISING IBUPROFEN AND DIPHENHYDRAMINE | HRH1, HRH4, HRH2 | ADORA3 170/4885AKT1 3937/4885CDC25A 1974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.